Literature DB >> 7897155

Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects.

Y Igarashi1, M S Goldrich, M A Kaliner, A M Irani, L B Schwartz, M V White.   

Abstract

BACKGROUND: The role of inflammatory cells at the local site of allergic inflammation in the nose is unclear.
METHODS: Nasal biopsy specimens were obtained from 10 patients with symptomatic seasonal allergic rhinitis and 10 normal subjects. Freeze-dried paraffin-embedded sections were stained for mononuclear cells and eosinophils. Tissues in Carnoy's fixative were stained for mast cells.
RESULTS: T cells were much more plentiful than B cells or macrophages, and no significant differences were found between the two groups in the number of T cells, T-cell subsets, B cells, and macrophages. However, the number of CD25+ cells (lymphocyte activation markers) and the number of eosinophils were significantly higher in the allergic group than in the control group. There were no significant differences between the two groups in the total mast cell number. However, mucosal type mast cells were slightly increased, and a higher ratio of mast cells were costained for IgE in the allergic group. IgE+ cells mostly constained for mast cell tryptase and did not costain for J chain.
CONCLUSIONS: These data suggest that unlike granulocytes, in some mononuclear cells qualitative, not quantitative, changes may be important in allergic rhinitis and that IgE may not be locally produced in the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897155     DOI: 10.1016/s0091-6749(95)70177-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis.

Authors:  O-P Alho; R Karttunen; T J Karttunen
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Interleukin-4 and interferon-gamma synergistically increase secretory component gene expression, but are additive in stimulating secretory immunoglobulin A release by Calu-3 airway epithelial cells.

Authors:  S Loman; H M Jansen; T A Out; R Lutter
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

3.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

4.  The pathophysiology, diagnosis and treatment of allergic rhinitis.

Authors:  Yang-Gi Min
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

5.  Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.

Authors:  Christin Wolfram; Claudia Rasche; Heike Audring; Michael Wahls; Margitta Worm
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-03       Impact factor: 2.503

6.  Lymphocyte and mast cell counts are increased in the nasal mucosa in symptomatic natural colds.

Authors:  O-P Alho; T J Karttunen; R Karttunen; H Tuokko; M Koskela; M Uhari
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

7.  Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1β-activated human mast cells were inhibited by Baicalein via regulation of the NF-κB pathway.

Authors:  David S Chi; Ta-Chang Lin; Kenton Hall; Tuanzhu Ha; Chuanfu Li; Zong Doa Wu; Thomas Soike; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2012-02-06

8.  Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway.

Authors:  Chia-Jung Hsieh; Kenton Hall; Tuanzhu Ha; Chuanfu Li; Guha Krishnaswamy; David S Chi
Journal:  Clin Mol Allergy       Date:  2007-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.